Charles E Geyer, John Forster, Deborah Lindquist, Stephen Chan, C Gilles Romieu, Tadeusz Pienkowski, Agnieszka Jagiello-Gruszfeld, John Crown, Arlene Chan, Bella Kaufman, Dimosthenis Skarlos, Mario Campone, Neville Davidson, Mark Berger, Cristina Oliva, Stephen D Rubin, Steven Stein, David Cameron. N Engl J Med 2006
Times Cited: 2289
Times Cited: 2289
Sherene Loi, Anita Giobbie-Hurder, Andrea Gombos, Thomas Bachelot, Rina Hui, Giuseppe Curigliano, Mario Campone, Laura Biganzoli, Hervé Bonnefoi, Guy Jerusalem, Rupert Bartsch, Manuela Rabaglio-Poretti, Roswitha Kammler, Rudolf Maibach, Mark J Smyth, Angelo Di Leo, Marco Colleoni, Giuseppe Viale, Meredith M Regan, Fabrice André. Lancet Oncol 2019
Times Cited: 192
Times Cited: 192
List of shared articles
Times cited
Updated Austrian treatment algorithm in HER2+ metastatic breast cancer.
Rupert Bartsch, Simon Peter Gampenrieder, Gabriel Rinnerthaler, Edgar Petru, Daniel Egle, Andreas Petzer, Marija Balic, Ursula Pluschnig, Thamer Sliwa, Christian Singer. Wien Klin Wochenschr 2022
Rupert Bartsch, Simon Peter Gampenrieder, Gabriel Rinnerthaler, Edgar Petru, Daniel Egle, Andreas Petzer, Marija Balic, Ursula Pluschnig, Thamer Sliwa, Christian Singer. Wien Klin Wochenschr 2022
Anti-HER2 therapy in metastatic breast cancer: many choices and future directions.
Carrie S Wynn, Shou-Ching Tang. Cancer Metastasis Rev 2022
Carrie S Wynn, Shou-Ching Tang. Cancer Metastasis Rev 2022
Developments in the Management of Metastatic HER2-Positive Breast Cancer: A Review.
Julie Lebert, Evan J Lilly. Curr Oncol 2022
Julie Lebert, Evan J Lilly. Curr Oncol 2022
Evolving management of HER2+ breast cancer brain metastases and leptomeningeal disease.
Matthew N Mills, Whitney King, Aixa Soyano, Yolanda Pina, Brian J Czerniecki, Peter A Forsyth, Hatem Soliman, Hyo S Han, Kamran A Ahmed. J Neurooncol 2022
Matthew N Mills, Whitney King, Aixa Soyano, Yolanda Pina, Brian J Czerniecki, Peter A Forsyth, Hatem Soliman, Hyo S Han, Kamran A Ahmed. J Neurooncol 2022
Targeting HER2+ Breast Cancer Brain Metastases: A Review of Brain-Directed HER2-Directed Therapies.
Lauren Chiec, Priya Kumthekar. CNS Drugs 2022
Lauren Chiec, Priya Kumthekar. CNS Drugs 2022
[New therapeutic strategies in HER2-positive breast cancer].
Benoîte Mery, Philippe Toussaint, Pierre-Etienne Heudel, Armelle Dufresne, Mélodie Carbonnaux, Hélène Vanacker, Thomas Bachelot, Olivier Trédan. Bull Cancer 2021
Benoîte Mery, Philippe Toussaint, Pierre-Etienne Heudel, Armelle Dufresne, Mélodie Carbonnaux, Hélène Vanacker, Thomas Bachelot, Olivier Trédan. Bull Cancer 2021
Neu Perspectives, Therapies, and Challenges for Metastatic HER2-Positive Breast Cancer.
Mohamad Adham Salkeni, Wajeeha Rizvi, Kyaw Hein, Gerald M Higa. Breast Cancer (Dove Med Press) 2021
Mohamad Adham Salkeni, Wajeeha Rizvi, Kyaw Hein, Gerald M Higa. Breast Cancer (Dove Med Press) 2021
The management of HER2-positive early breast cancer: Current and future therapies.
Julia Chen, Maree Colosimo, Elgene Lim. Asia Pac J Clin Oncol 2021
Julia Chen, Maree Colosimo, Elgene Lim. Asia Pac J Clin Oncol 2021